Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
0.62
0.01 (0.81%)
At close: May 16, 2025, 10:36 AM
0.81% (1D)
| Bid | 0.61 |
| Market Cap | 10.64M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.6M |
| EPS (ttm) | -0.23 |
| PE Ratio (ttm) | -2.71 |
| Forward PE | -1.34 |
| Analyst | Buy |
| Ask | 0.62 |
| Volume | 40,403 |
| Avg. Volume (20D) | 124,590 |
| Open | 0.63 |
| Previous Close | 0.61 |
| Day's Range | 0.62 - 0.62 |
| 52-Week Range | 0.57 - 4.00 |
| Beta | 2.89 |
About KAPA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KAPA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KAPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+0.5%
Kairos Pharma shares are trading higher after the ...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Kairos Pharma Announces New Department of Defense Funding for Research of ENV205LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership with Cedars-Sinai Medical Center, C...